LISINOPRIL
- Product NDC
- 61919-909
- 11-digit product format
- 619190909
- Labeler code
- 61919
- Product ID
- 61919-909_cdba624d-b0ca-0a5e-e053-2a95a90a4e25
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- LISINOPRIL
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Direct_Rx
- Application
- ANDA076180
- Marketing category
- ANDA
- Marketing start
- 2019-08-28
- Marketing end
- 0000-00-00
- Substance
- LISINOPRIL
- Active strength
- 5 mg/1
- Pharmacologic classes
- Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 61919-909-30 | LISINOPRIL | 30 in 1 BOTTLE | TABLET | 30 | | 3 |
| 61919-909-90 | LISINOPRIL | 90 in 1 BOTTLE | TABLET | 90 | | 3 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 61919-909 | LISINOPRIL TABLET [DIRECT_RX] | 3 | Legacy NDC, 2 package rows | 20211008_91321ca0-f2dd-f66c-e053-2995a90a8342.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 61919-909-30 | 61919090930 | 30 TABLET in 1 BOTTLE (61919-909-30) | 30 tablet | 2019-08-28 | 0000-00-00 | No | No | Current |
| 61919-909-90 | 61919090990 | 90 TABLET in 1 BOTTLE (61919-909-90) | 90 tablet | 2019-08-28 | 0000-00-00 | No | No | Current |